🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share an editorial I wrote for NEJM Evidence on why we should consider "breaking free" from the hazard ratio and begin "embracing" the RMST! Harvard Medical School Harvard T.H. Chan School of Public Health NEJM Evidence evidence.nejm.org/stoken/default…

Combinations, Sequencing, and the Contribution of Components: New Frontline Standards for Metastatic Urothelial Carcinoma ascopubs.org/doi/10.1200/JC… Nice commentary including socioeconomic/financial toxicity of EV+Pembro...

EV302- enfortumab vedotin and Pembrolizumab met its dual primary endpoints of OS and PFS with ‘clinically meaningful’ improvement versus chemotherapy in patients with previously untreated la/mUC. merck.com/news/merck-ann…

Our team, taking over the urothelial and testis cancer session at Western Section AUA (as always 😉) Thanks to our mentors Sia Daneshmand, M.D. and Dr. Hooman Djaladat USC Urology! Erika L. Wood, MD,MPH Leilei Xia Farshad Sheybaee Moghaddam

nature.com/articles/s4159… Sumanta K. Pal, MD, FASCO Sia Daneshmand, M.D. Ronac Mamtani Horowitz Lab @Icahn School of Medicine Mount Sinai Reza Mehrazin, MD Bhardwaj Lab Dr. John Sfakianos Neeraj Agarwal, MD, FASCO Hoosier Cancer Icahn School of Medicine at Mount Sinai Lipschultz Precision Immunology Institute

RSVP & save the date for the world-class discussion on #testiscancer hosted by Sia Daneshmand, M.D. and Phillip Pierorazio as VP! Dr. Hooman Djaladat Muhannad Alsyouf Erika L. Wood, MD,MPH Leilei Xia Rob Hamilton DrBagrodia Scott Eggener Society of Urologic Oncology YUO USC Urology Penn Urology Testicular Cancer

In our evaluation of 42 cystectomy patients, social deprivation index predicted complications and readmissions at 30 and 90 days. Grateful to be a part of this team. Society of Urologic Oncology #SUO23 Erika L. Wood, MD,MPH Sia Daneshmand, M.D. Farshad Sheybaee Moghaddam USC Urology Leilei Xia Sanam Ladi Seyedian Muhannad Alsyouf

A roundtable discussion led by Dr. Christopher Wallis (he/him/his) featuring Drs. Sia Daneshmand, M.D., Piyush Kumar Agarwal, and Sima Porten focused on patient selection and new therapies for non-muscle invasive #bladdercancer, as well as recent data from #SUO2023. Watch here: buff.ly/3GE2BdG

Great discussion about the dilemma of follow up imaging in screening for late recurrence testicular cancer between Sia Daneshmand, M.D. and Phillip Pierorazio. Grateful to share in the wisdom of such distinguished physicians. USC Urology

🔥Just published in Journal of Urology 1️⃣The first US RCT on prophylactic mesh in ileal conduit led by Dr. Hooman Djaladat (2015-2023) ▶️Biologic mesh placement is feasible with no AEs ▶️No protective effect within 2yr FU 🔗auajournals.org/doi/10.1097/JU… Amer. Urol. Assn. USC Urology Radiology of USC

Midline extraperitoneal #RPLND (primary or post chemo) reduces surgical morbidity, eliminates ileus with short hospital stay (contemporary 90% discharge POD #1) Saum Ghodoussipour Brian Hu Muhannad Alsyouf Sunil Patel MD Hamed Ahmadi MD DrBagrodia Rob Hamilton

Diverse immigrants make the US better - Nobel Laureates! Countless physicians and surgeons 👏 nytimes.com/2024/06/19/opi…

🔥Hot off the press in Journal of Urology. Kudos to Muhannad Alsyouf and Sia Daneshmand, M.D.! 1⃣237 EP-RPLNDs 2⃣Median LOS: 2d 3⃣30d complications: 13%; no postop ileus or SBO 4⃣Great onc outcomes in primary and post-chemo settings; 7 in-field recurrences 🔗Free access link: auajournals.org/doi/10.1097/JU…

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study by Pawel Rajwa et al buff.ly/3XS75p8 #UroSoMe #MedTwitter #PCa #ProstateCancer

🚨Not all #prostatecancer BCRs are created equally!!🚨 👉Many interesting takeaways in this Swedish population-based study after prostatectomy JNCI 1⃣Half of pts w/ high-risk PCa recur within 10 years 2⃣Death from PCa at 10yr was 9% for high-risk European Association of Urology (EAU) BCR & 2.2% for

Perfect time to plug in the PRESERVE Trial. Through a single blind RCT, we will compare PROs between external oblique fascia sparing orchiectomy to standard inguinal orchiectomy. If anyone interested please reach out, trial to open soon! clinicaltrials.gov/study/NCT06828…

#aua25 Great NMI #Bladdercancer Plenary debates. Gem/Doce is absolute 🔥. Look forward to BRIDGE trial results to see if can dethrone BCG itself.

🚨New in @EUPlatinum! 📌 PSMA PET for Prostate Cancer Diagnosis & Staging by Elio Mazzone et al 🧠 This comprehensive meta-analysis confirms the high diagnostic value of PSMA PET—especially when combined with MRI—but reminds us it’s not enough to skip biopsy or lymph node